HONG KONG, Feb. 13, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China National Medical Products Administration (NMPA) for AK139, a bispecific antibody targeting IL-4Rα...
Read More Details
Finally We wish PressBee provided you with enough information of ( Akeso Announces IND Acceptance for AK139, a Bispecific Antibody Targeting IL-4Rα and ST2 for Respiratory and Skin Diseases )
Also on site :
- Emmy Predictions: Talk/Scripted Variety Series — The Variety Categories Are Still a Mess; Netflix, Dropout, and ‘Hot Ones’ Stir Up Buzz
- Ex-Bellingcat child porn researcher commits suicide after conviction for abusing own child – media
- Khloe Kardashian and Podcaster Totally Gush Over Each Other and Fans Are Swooning